CannaGrowth.com | Aphria cutting US marijuana exposure amid delisting review
27646
post-template-default,single,single-post,postid-27646,single-format-standard,ajax_fade,page_not_loaded,,vertical_menu_enabled,side_area_uncovered_from_content,qode-theme-ver-7.2,wpb-js-composer js-comp-ver-4.5.1,vc_responsive

Aphria cutting US marijuana exposure amid delisting review

12 Dec Aphria cutting US marijuana exposure amid delisting review

Aphria is scrambling to shed direct involvement in American medical cannabis businesses as it undergoes a delisting review by its stock exchange operator. The Leamington, Ontario-based company has been in the hot seat since the TMX Group – parent of the Toronto Stock Exchange and the TSX Venture Exchange – said companies with direct business […] Aphria cutting US marijuana exposure amid delisting review is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

The post Aphria cutting US marijuana exposure amid delisting review appeared first on InvestinCannabis.com.

No Comments

Sorry, the comment form is closed at this time.